AzTrials
AzTrials

Smoking (Tobacco) AddictionNCT07553962

Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt

An observational study of Smoking (Tobacco) Addiction and Smoking ( Cigarette), run by University of Colorado, Denver at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Smoking is the leading preventable cause of death in the United States, and quitting is especially difficult for couples who both smoke. When both partners smoke, they are less likely to quit successfully and more likely to relapse compared to people whose partner does not smoke. Read more about this study

Who is it for?
Ages 18 years and older
How many people
250 participants
Where
1 siteUnited States
Study dates
20 Mar 2025to 1 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Dual-smoking couples residing in the United States

Who may be able to join

  • Are over the age of 18
  • Smoke cigarettes on a daily basis
  • Smoke at least 5 cigarettes per day on average
  • Are in a committed relationship with an individual who smokes at least 5 cigarettes per day on average and is willing to participate in the study
  • Are willing to make a smoking cessation attempt at the time of enrollment into the study (applies to only one partner).

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Slaton Z Freeman, M.A. contact

512-755-1814

zane.freeman@ucdenver.edu

United States1 site, 1 recruiting
  • University of Colorado Denver

    Denver, Colorado, 80204

    Zane Freeman, M.A, 512-755-1814, zane.freeman@ucdenver.edu

    Recruiting

Other trials in United States

About this study

Official title: Communal Coping in Dual-Smoking Couples During a Quit Attempt

Smoking is the leading preventable cause of death in the United States, and quitting is especially difficult for couples who both smoke. When both partners smoke, they are less likely to quit successfully and more likely to relapse compared to people whose partner does not smoke. Research suggests that the way romantic partners interact and support each other during a quit attempt can make a real difference - but researchers do not yet know enough about what kinds of support actually help.

This study examines a concept called "communal coping," which refers to when partners treat a shared health challenge - like quitting smoking - as something they are facing together as a team rather than as separate individuals. Researchers believe that couples who approach quitting this way may have better outcomes.

To study this, researchers will ask both members of dual-smoking couples to complete brief daily surveys over two weeks while making a quit attempt. These surveys will track how partners support (or discourage) each other's quitting efforts on a day-to-day basis, along with cigarette use, cravings, and stress. This will help researchers understand which relationship patterns are most helpful for quitting, and identify specific targets for future couples-based smoking cessation programs.

Keywords
smoking cessation, tobacco, cigarette, relationships
Medical subject headings
Smoking, Behavior, Addictive, Cigarette Smoking, Smoking Cessation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-report of smoking abstinence

    Participants will report how many cigarettes they smoked (or didn't smoke) in their daily diary surveys.

    Measured: Daily for the first two weeks of the study period, and in the follow-up survey two weeks later.

  2. Concentration of carbon monoxide found in lungs.

    Participants will use a carbon monoxide breathalyzer and report the results in their daily diary surveys.

    Measured: Daily for the first two weeks of the study.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2026
  2. Study start20 Mar 2025
  3. Primary completion1 Aug 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07553962
Sponsor's protocol ID
23-2285
Status last verified
May 2026
First submitted
13 Apr 2026
Last updated
15 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Smoking (Tobacco) Addiction and Smoking ( Cigarette), run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Slaton Z Freeman, M.A. (512-755-1814, zane.freeman@ucdenver.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-report of smoking abstinence (time frame: Daily for the first two weeks of the study period, and in the follow-up survey two weeks later.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in